Research shows pullulan improves allergen-specific immunotherapy efficacy in dogs, suggesting its role as an adjuvant.
Pullulan may enhance AIT efficacy in CAD, supporting its potential role as an immunotherapeutic adjuvant independent of allergen source.
No takes yet. Share an insight, caveat, or question.
Martini et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: